RL
ABBV icon

Rogco LP’s AbbVie ABBV Stock Holding History

Rogco LP’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Sell
6,390
-160
-2% -$34.4K 0.49% 29
2026
Q1 		$1.42M Sell
6,550
-165
-2% -$36.6K 0.48% 31
2025
Q4 		$1.53M Sell
6,715
-83
-1% -$18.9K 0.51% 29
2025
Q3 		$1.57M Sell
6,798
-423
-6% -$86.1K 0.55% 29
2025
Q2 		$1.34M Sell
7,221
-615
-8% -$114K 0.5% 29
2025
Q1 		$1.64M Buy
7,836
+89
+1% +$17.3K 0.66% 28
2024
Q4 		$1.38M Sell
7,747
-385
-5% -$70.8K 0.56% 32
2024
Q3 		$1.61M Sell
8,132
-929
-10% -$173K 0.63% 30
2024
Q2 		$1.55M Buy
9,061
+145
+2% +$24K 0.63% 30
2024
Q1 		$1.62M Sell
8,916
-6,382
-42% -$1.1M 0.66% 28
2023
Q4 		$2.37M Buy
15,298
+2,481
+19% +$362K 1.04% 19
2023
Q3 		$1.91M Buy
+12,817
New +$1.88M 0.94% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rogco LP's ABBV Position: Q2 2026 in Review

Rogco LP reduced its AbbVie (ABBV) stake by 2.4% in Q2 2026, selling an estimated $34.4K and leaving 6,390 shares worth $1.61M. The position accounts for 0.49% of the portfolio, ranked #29.

Rogco LP first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.37M in Q4 2023. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rogco LP held 6,390 shares of AbbVie worth $1.61M as of Q2 2026.
  • Rogco LP sold 160 AbbVie shares in Q2 2026, an estimated $34.4K.
  • AbbVie made up 0.49% of Rogco LP's portfolio in Q2 2026, its #29 holding.
  • Rogco LP first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • Rogco LP's AbbVie position peaked at $2.37M in Q4 2023.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rogco LP's 13F filing for Q2 2026, filed 30 Jul 2026.